TY  - CONF

T1  - Non-inferiority of oral ibandronate to intravenous zoledronic acid for reducing markers of bone turnover in metastatic breast cancer patients

JO  - BREAST CANCER RESEARCH AND TREATMENT

PY  - 2005/01/01

AU  - Lichinitser MR

AU  - Coleman RE

AU  - Tjulandin SA

AU  - Bergstrom B

AU  - Body JJ

ED  - 

VL  - 94

SP  - S259

EP  - S259

Y2  - 2025/10/10

ER  -